Countering Medicines Trafficking in Russia in the Context of the COVID-19 Pandemic: Key Problems and Ways to Solve Them
https://doi.org/10.47361/2542-0259-2021-1-25-52-59
Abstract
The article examines a number of key problems in the fight against illicit medicines trafficking in Russia in the context of the COVID-19 pandemic and the development of a set of organizational and legal measures to increase the effectiveness of such a fight. The author concludes that the scale and severity of the various consequences caused by the COVID-19 pandemic are, to a certain extent, due to imperfect state control over the shadow pharmaceutical sector. In particular, many standard measures of government response to drug trafficking are not effective enough to ensure reliable protection of the population from the negative impact of illegal circulation of counterfeit, substandard, unregistered, counterfeit drugs.
The measures proposed by the author are aimed at improving the efficiency of the system for preventing drug trafficking not only in relation to the modern conditions of the COVID-19 pandemic, but also designed to ensure state control over the production and circulation of drugs in any emergency conditions.
About the Author
A. V. Egorov
State Institute of Drugs and Good Practices; All-Russian State University of Justice (RLA of the Ministry of Justice of Russia)
Russian Federation
Russian Federation
Andrey V. Egorov
Lavrov lane, 6, Moscow, 109044; Azovskaya str., 2, bldg 1, Moscow, 1117638
References
1. Shandra M. Yu. Legal regulation of the circulation of medicines in the consumer market of the Russian Federation: Abstract diss. ... candidate of legal sciences: 12.00.03. Sib. feder. un-t. Krasnoyarsk, 2018. 21 p. (In Russ.)
2. Bolotin I. V. Problems of administrative responsibility for anoffence in the field of drugs turnover, psychotropic substances and theirprecursores // Central Russian Journal of Social Sciences. 2015. Vol. 10. No. 5. P. 131 — 139 (In Russ.) DOI: 10.12737/14306
3. Beygulenko S. A. Organization compliance of modern russian pharmaceutical corporations // Finansovye issledovania. 2016. No. 1 (50). P. 12—19 (In Russ.)
4. Varlamova A. N. Competition law and industrial commodity markets: the medicinal product market // Competition Law. 2018. No. 4. P. 3—7 (In Russ.)
5. Kolesnikov S. I., Dyndikov I. N. Forecast of the consequences of the adoption draft bill No. 912246-7 on amendments to the legislation on the circulation of medicines and health care for the Russian pharmaceutical market // Russian Competition Law and Economics. 2020. No. 2 (22). P. 72—81 (In Russ.)
6. Terekhov A. Yu. International legal means of preventing the circulation of counterfeit medicinal products: Diss... cand. jurid. sciences. M., 2011,32 p. (In Russ.)
7. Vancauwenberghe, Roy. Pharmaceutical Crime // UNODC Conference on Fraudulent Medicines. Vienna, 2013. February, 14—15th.
8. Rarog A. I., Ponyatovskaya T. G., Bimbinov A. A., Voronin V. N. Pharmaceutical criminal law of Russia: Mоnography. M.: MGYuA, 2019. 216 p. (In Russ.)
9. Egorov A. V., Rudaya T. Yu. “White-collar” crime in the pharmaceutical sector // Criminal policy of the Russian Federation. Monograph. Common ed. S. V. Maksimov and V. L. Shultz. Resp. ed. S. A. Bochkarev. M.: Prospect, 2021. P 326—339 (In Russ.)
10. Braithwaite John. Corporate crime in the pharmaceutical industry (1. publ. ed.). London: Routledge & Kegan Paul 1984. 448 p.
11. Parkhomenko D. V. Theoretical foundations and organizational and methodological approaches to ensuring the national security of Russia in the field of drug circulation: Diss. ... doct. farm. nauk), Moscow, 2005, 260 p. (In Russ.)
12. Maksimov S. V. Consequences of the COVID-19 pandemic — the main findings are ahead // Russian Competition Law and Economics, 2020. No. 2 (22). P. 4—5 (In Russ.)
13. Maksimov S. V., Vasilenko I. A. Commentary on the Russian legislation on the accreditation of persons involved in the control of pharmaceutical enterprises // Development and registration of medicines. 2015. No. 3. P. 192—197 (In Russ.)
Review
For citations:
Egorov A.V. Countering Medicines Trafficking in Russia in the Context of the COVID-19 Pandemic: Key Problems and Ways to Solve Them. Russian competition law and economy. 2021;(1):52-59. (In Russ.) https://doi.org/10.47361/2542-0259-2021-1-25-52-59
Views:
464
Email this article 